Market Insights Health OTC Pharmaceuticals

Analgesics - Denmark

Denmark

In Denmark, the revenue generated in the Analgesics market in 2024 amounts to US$33.90m.
It is projected to experience an annual growth rate of 5.11% (CAGR 2024-2029).
When compared to other countries worldwide, the in the United States leads with a revenue of US$7,243.00m in 2024.
Considering the total population, per person revenues of US$5.71 are generated in Denmark in 2024.
Denmark's OTC analgesics market is witnessing a growing preference for natural and herbal remedies among consumers.

Key regions: Canada, United States, United Kingdom, Australia, Germany

Market

Region

Region comparison

Currency

Analyst Opinion

The Analgesics market in Denmark is experiencing steady growth due to various factors such as changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.

Customer preferences: In Denmark, customers are increasingly seeking pain relief options that are convenient, effective, and have minimal side effects. As a result, there is a growing demand for analgesics that are available over-the-counter (OTC) without the need for a prescription. Customers also prefer analgesics that provide long-lasting relief and have a quick onset of action. Additionally, there is a rising preference for natural and herbal remedies, leading to an increase in the demand for alternative pain relief options.

Trends in the market: One of the key trends in the Analgesics market in Denmark is the growing popularity of non-opioid analgesics. This trend is driven by the increasing awareness about the potential risks and side effects associated with opioid-based pain medications. As a result, customers are opting for non-opioid analgesics such as nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen. Another trend in the market is the rising demand for topical analgesics, which offer localized pain relief and are easy to apply. These topical analgesics are available in various forms such as creams, gels, and patches.

Local special circumstances: Denmark has a well-developed healthcare system with a strong emphasis on preventive care and patient education. This has led to a high level of health awareness among the population, resulting in proactive management of pain and a greater willingness to seek appropriate treatment. Additionally, Denmark has a high proportion of elderly population, who are more likely to experience chronic pain conditions. This demographic factor contributes to the overall demand for analgesics in the country.

Underlying macroeconomic factors: The Analgesics market in Denmark is influenced by various macroeconomic factors. One such factor is the overall economic growth of the country. As the economy grows, disposable incomes increase, allowing individuals to spend more on healthcare products, including analgesics. Another factor is the government's healthcare policies and regulations. Denmark has a universal healthcare system, which ensures access to healthcare services for all residents. The government's focus on providing affordable and accessible healthcare contributes to the demand for analgesics.In conclusion, the Analgesics market in Denmark is driven by changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. The growing demand for OTC analgesics, non-opioid options, and topical analgesics reflects the evolving needs of customers. The high level of health awareness and the presence of a significant elderly population in Denmark also contribute to the demand for analgesics. Additionally, the overall economic growth and the government's healthcare policies play a role in shaping the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.